Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,204 | -19,314 | -12,032 | -5,772 | -26,767 |
| Depreciation Amortization | 73 | 55 | 37 | 17 | 272 |
| Accounts receivable | 32 | 46 | 30 | 17 | 31 |
| Other Working Capital | -525 | -75 | 376 | -106 | -680 |
| Other Operating Activity | 7,551 | 5,764 | 3,128 | 861 | 8,854 |
| Operating Cash Flow | $-17,073 | $-13,523 | $-8,462 | $-4,982 | $-18,289 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -16 | -13 | -8 | -16 |
| Investing Cash Flow | $-18 | $-16 | $-13 | $-8 | $-16 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,503 | 25 | 25 | N/A | 15,715 |
| Other Financing Activity | -381 | -30 | -20 | -10 | -1,965 |
| Financing Cash Flow | $11,122 | $-5 | $5 | $-10 | $13,750 |
| Exchange Rate Effect | -590 | -218 | -484 | -75 | 1,379 |
| Beginning Cash Position | 21,886 | 22,198 | 22,109 | 21,296 | 25,493 |
| End Cash Position | 15,328 | 8,437 | 13,155 | 16,221 | 22,317 |
| Net Cash Flow | $-6,558 | $-13,761 | $-8,954 | $-5,075 | $-3,176 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,073 | -13,523 | -8,462 | -4,982 | -18,289 |
| Capital Expenditure | -18 | -16 | -13 | -8 | -16 |
| Free Cash Flow | -17,090 | -13,539 | -8,476 | -4,990 | -18,305 |